1. Home
  2. VERU vs PROV Comparison

VERU vs PROV Comparison

Compare VERU & PROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • PROV
  • Stock Information
  • Founded
  • VERU 1971
  • PROV 1956
  • Country
  • VERU United States
  • PROV United States
  • Employees
  • VERU N/A
  • PROV N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • PROV Savings Institutions
  • Sector
  • VERU Health Care
  • PROV Finance
  • Exchange
  • VERU Nasdaq
  • PROV Nasdaq
  • Market Cap
  • VERU 85.5M
  • PROV 100.7M
  • IPO Year
  • VERU 1990
  • PROV 1996
  • Fundamental
  • Price
  • VERU $3.60
  • PROV $15.46
  • Analyst Decision
  • VERU Strong Buy
  • PROV Hold
  • Analyst Count
  • VERU 3
  • PROV 1
  • Target Price
  • VERU $33.33
  • PROV $16.50
  • AVG Volume (30 Days)
  • VERU 227.6K
  • PROV 3.7K
  • Earning Date
  • VERU 08-12-2025
  • PROV 07-28-2025
  • Dividend Yield
  • VERU N/A
  • PROV 3.64%
  • EPS Growth
  • VERU N/A
  • PROV N/A
  • EPS
  • VERU N/A
  • PROV 0.93
  • Revenue
  • VERU $16,886,419.00
  • PROV $39,666,000.00
  • Revenue This Year
  • VERU N/A
  • PROV $10.39
  • Revenue Next Year
  • VERU N/A
  • PROV $1.56
  • P/E Ratio
  • VERU N/A
  • PROV $16.54
  • Revenue Growth
  • VERU 337.24
  • PROV 1.90
  • 52 Week Low
  • VERU $2.64
  • PROV $12.91
  • 52 Week High
  • VERU $14.20
  • PROV $16.70
  • Technical
  • Relative Strength Index (RSI)
  • VERU 35.24
  • PROV 40.27
  • Support Level
  • VERU $2.64
  • PROV $15.02
  • Resistance Level
  • VERU $3.69
  • PROV $15.57
  • Average True Range (ATR)
  • VERU 0.39
  • PROV 0.21
  • MACD
  • VERU 0.02
  • PROV -0.01
  • Stochastic Oscillator
  • VERU 40.27
  • PROV 18.03

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About PROV Provident Financial Holdings Inc.

Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. Through the bank, it is engaged in providing community and mortgage banking services to consumers and small to mid-sized businesses in the Inland Empire region of Southern California. The company's business segment is Bank. The Bank's activities include attracting deposits, offering banking services, and originating and purchasing single-family, multi-family, commercial real estate, construction, and other mortgage loans and, to a lesser extent, commercial business and consumer loans held for investment.

Share on Social Networks: